Stoke Therapeutics (STOK) earnings, Oct 29, 2026: EPS −66%, stock −0.2%
In brief
Stoke Therapeutics reported on Oct 29, 2026. Earnings per share changed −66% year over year, 16.2% below the estimate; revenue +6%. The stock opened with a −1.2% gap and closed the day −0.2% (Oct 30, 2026). The stock is now 35.2% below its 52-week high, +14.2% over 12 months. Next report: Mar 16, 2027.
EPS vs estimate−16.2%
EPS, YoY−66%
Revenue, YoY+6%
Gap · day−1.2% · −0.2%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 3, 2026 | −2.6% | +7.1% |
| Oct 29, 2026 | −1.2% | −0.2% |
Next-quarter estimates, ratings and the STOK chart are in the terminal.
Open the terminalFAQ
When is Stoke Therapeutics's next earnings report?
Mar 16, 2027. The date comes from daily data and is corrected if the company moves it.
How did Stoke Therapeutics stock react to the report?
Opening gap −1.2%, day's result −0.2%.
Did Stoke Therapeutics's earnings grow?
Earnings per share fell 66% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.